10x Genomics (TXG) Receivables - Other (2024 - 2026)

10x Genomics (TXG) posted Receivables - Other of -$18.1 million for Q1 2026, down 151.1% sequentially from $35.5 million in Q4 2025.

10x Genomics (TXG) Receivables - Other (2024 - 2026) Analysis & Trends

10x Genomics has reported Receivables - Other for 3 years, with the latest figure at -$18.1 million in Q1 2026.

Quarterly Receivables - Other changed N/A year-over-year to -$18.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.2 million (changed N/A YoY) and the FY2025 annual result came in at $35.5 million, up 5754.79% from the prior year.
Receivables - Other retreated to -$18.1 million in Q1 2026 per TXG's latest filing, from $35.5 million in the prior quarter.
Over five years, Receivables - Other peaked at $69.1 million in Q2 2025 and troughed at -$18.1 million in Q1 2026.
A 3-year average of $27.8 million and a median of $35.5 million in 2025 frame the typical range for Receivables - Other.
The widest YoY moves for Receivables - Other: up 51877.45% in 2025, down 51877.45% in 2025.
Over 3 years, Receivables - Other stood at -$102000.0 in 2024, then jumped by 34884.31% to $35.5 million in 2025, then tumbled by 151.1% to -$18.1 million in 2026.
According to Business Quant data, Receivables - Other over the past three periods registered -$18.1 million, $35.5 million, and $52.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn
10	Privia Health	2.78 Bn	2.42 Bn	-

Download Data